Cited by 153SARS-CoV-2 and COVID-19 ResearchImmune responses and vaccinationsImmunotherapy and Immune Responses

The DOI matches its Crossref record; 7 of the 8 references it cites were found in a registry or an index.

Avoiding pitfalls in the pursuit of a COVID-19 vaccine

Open access

Peeples, Lynne·2020·Proceedings of the National Academy of Sciences

DOI 10.1073/pnas.2005456117PMC PMC7165470

Open this paper in CoChat — free account Open PDF

Abstract

As they race to devise a vaccine, researchers are trying to ensure that their candidates don't spur a counterproductive, even dangerous, immune system reaction known as immune enhancement.

Integrity signals

Registry

Crossref · 10.1073/pnas.2005456117

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Positive RT-PCR test results in patients recovered from COVID-19
Lan, L., Xu, D., Ye, G., Xia, C., Wang, S., Li, Y., & Xu, H. (2020) · JAMA · doi:10.1001/jama.2020.2783 · Cited by 1,251
A Double-Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine Provides Incomplete Protection in Mice and Induces Increased Eosinophilic Proinflammatory Pulmonary Response upon Challenge
Bolles, M., Deming, D., Long, K., Agnihothram, S., Whitmore, A., Ferris, M., Funkhouser, W., Gralinski, L., Totura, A., Heise, M., et al. (2011) · Journal of Virology · doi:10.1128/jvi.06048-11 · Cited by 477
Antibody-Dependent Enhancement of Virus Infection and Disease
Cancel-Tirado, S. M., & Yoon, K. J. (2003) · Viral Immunology · doi:10.1089/088282403763635465 · Cited by 316
Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization
Vennema, H., de Groot, R. J., Harbour, D. A., Dalderup, M. J. M., Gruffydd-Jones, T., Horzinek, M. C., & Spaan, W. J. M. (1990) · Journal of Virology · doi:10.1128/jvi.64.3.1407-1409.1990 · Cited by 276
Brief History and Characterization of Enhanced Respiratory Syncytial Virus Disease
Acosta, P. L., Caballero, M. T., & Polack, F. P. (2015) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00609-15 · Cited by 259
Immune Enhancement of Viral Infection
Halstead, S. B. (2015) · Chemical immunology/Fortschritte der Allergielehre/Progress in allergy/Chemical immunology and allergy · doi:10.1159/000406537 · Cited by 210
Medical Countermeasures Analysis of 2019-nCoV and Vaccine Risks for Antibody-Dependent Enhancement (ADE)Preprint
Ricke, D. O., & Malone, R. W. (2020) · SSRN Electronic Journal · doi:10.20944/preprints202003.0138.v1 · Cited by 48

Flagged first, then by citations

Show all 8 references

1 of the 8 references couldn’t be matched to a known paper.

Sorted by citations

Items 101–153 of 153

Phospholipids dock SARS-CoV-2 spike protein via hydrophobic interactions: a minimal in-silico study of lecithin nasal spray therapy
Qaisrani, M. N., Belousov, R., Rehman, J. U., Goliaei, E. M., Girotto, I., Franklin-Mergarejo, R., Güell, O., Hassanali, A. A., & Roldán, É. (2021) · The European Physical Journal E · doi:10.1140/epje/s10189-021-00137-3 · Cited by 5
Pandemic vaccine testing: Combining conventional and challenge studies
Gerhard, T., Strom, B. L., & Eyal, N. (2022) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.5429 · Cited by 3
Potential Consequence of Interconnected Intervention against Systemic Risk (COVID‐19) via a Model‐Driven Network‐Agent Dynamic
Park, C. (2022) · Complexity · doi:10.1155/2022/7382033 · Cited by 2
The impact of lymphoid memory cells in different ages of COVID-19 patients
Jafari, M., Kolahdooz, H., Mahmoudi, M., Azarnaminy, A. F., Mobasheri, L., & Esmaeili, S. (2022) · Gene Reports · doi:10.1016/j.genrep.2022.101503 · Cited by 3
Personalized Therapy of Infectious Diseases
Jain, K. K. (2020) · Springer eBooks · doi:10.1007/978-3-030-62080-6_15 · Cited by 3
Designing a therapeutic SARS-CoV-2 T-cell-inducing vaccine for high-risk patient groupsPreprint
Rammensee, H., Stevanović, S., Gouttefangeas, C., Heidu, S., Klein, R., Preuß, B. E., Walz, J. S., Nelde, A., Haen, S. P., Reth, M. G., et al. (2020) · doi:10.21203/rs.3.rs-27316/v1 · Cited by 3
Coronavirus disease 2019 vaccination and menstrual cycle changes: A cross-sectional study on females of reproductive age in Saudi Arabia
Eskandar, M. A., Alassim, A., Riaz, F., Mahmood, S. E., Alshehri, N., Asim, A. A. A., Almodeer, M., & Ahmad, A. (2025) · Medicine · doi:10.1097/md.0000000000041656 · Cited by 2
IMMUNOLOGICAL RESPONSE TO SARS-COV 2 AND IMMUNOPATHOLOGY OF COVID-19 INFECTION
Abdul-Rahman, G. Y., & Mohammed, G. (2022) · MINAR International Journal of Applied Sciences and Technology · doi:10.47832/2717-8234.11.4 · Cited by 2
Addressing the global surge of COVID-19 cases: Insights from diagnostics, improved treatment strategies, vaccine development and application
Adedokun, K. A., Olarinmoye, A. O., Olayemi, L. O., Shehu, M. R., Mustapha, J. O., Kamorudeen, R. T., & Nassar, S. A. (2021) · Journal of Clinical and Translational Research · doi:10.18053/jctres.07.202102.002 · Cited by 2
Smart Contracts Implementation in the Allocation of Covid-19 Vaccines
Yazdani, M. A., Roy, D., & Hennequin, S. (2021) · IFIP advances in information and communication technology · doi:10.1007/978-3-030-85906-0_56 · Cited by 2
Research during Pandemics and Epidemics
Eyal, N. (2022) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780190947750.013.34 · Cited by 2
A predictive model for Covid-19 spread applied to six US statesPreprint
Khan, Z. S., Bussel, F. V., & Hussain, F. (2020) · arXiv (Cornell University) · Cited by 3
COVID-19 vaccine candidates: A review
Biała, M., Lelonek, E., & Knysz, B. (2021) · Postępy Higieny i Medycyny Doświadczalnej · doi:10.5604/01.3001.0014.7051 · Cited by 1
Development and evaluation of an 18F-labeled nanobody to target SARS-CoV-2's spike protein
van den Broek, S. L., Vázquez, R. G., Andersen, I. V., Valenzuela, G., Shalgunov, V., Battisti, U. M., Schwefel, D., Modhiran, N., Kramer, V., Cheuquemilla, Y., et al. (2022) · Frontiers in Nuclear Medicine · doi:10.3389/fnume.2022.1033697 · Cited by 1
RNA Interference: Antiviral Defense Mechanism and Immune Memory
Muratkhodjaev, J. N., & Aripova, T. U. (2020) · Advances in Applied Physiology · doi:10.11648/j.aap.20200502.13 · Cited by 1
Using COVID-19 deaths as a surrogate to measure the progression of the pandemicsPreprint
Hernández-Suárez, C., & Murillo‐Zamora, E. (2020) · medRxiv · doi:10.1101/2020.09.27.20202564 · Cited by 1
COVID-19 PANDEMICS: HOW FAR ARE WE FROM HERD IMMUNITY?Preprint
Hernández-Suárez, C., Murillo‐Zamora, E., & Espinoza‐Gómez, F. (2020) · medRxiv · doi:10.1101/2020.12.19.20248571 · Cited by 1
SARS‐CoV‐2 vaccination—A plea for fast and coordinated action
Beer, M., Doherr, M., Osterrieder, K., Pfeiffer, D. U., & Trimpert, J. (2020) · Zoonoses and Public Health · doi:10.1111/zph.12740
Withdrawn: Theoretical novel COVID-19 vaccination risk of rare and severe adverse events versus COVID-19 mortality
Grech, V., & Neville, C. (2020) · Early Human Development · doi:10.1016/j.earlhumdev.2020.105212
Retracted
Covid-19 Vaccine - When Will We Have One? Uncertainty, Hope, Early Warnings And Adult Mental Health
Bekiroğulları, Z. (2020) · European Proceedings of Health · doi:10.15405/eph.20101.6
Virus Vaccine Induced Immune Enhancement Mechanisms
Snawa, I. (2021) · Journal of Health, Medicine and Nursing · doi:10.7176/jhmn/86-05
Estimation of Basic Reproduction Number and Herd Immunity for COVID-19 in India
Majumder, P., & Ray, P. P. (2021) · Studies in big data · doi:10.1007/978-981-16-0415-7_13
Spectrum of COVID-19: A Disorder of Multisystem Beyond Respiratory Disease
Luo, J. J., & Dun, N. J. (2020) · Journal of Neurology and Experimental Neuroscience · doi:10.17756/jnen.2020-s1-004
COVID-19 immunity and vaccines: what a pharmacist needs to know
Darwish, R. M. (2021) · Asian Biomedicine · doi:10.2478/abm-2021-0008
A Retrospective Assessment of the Initial Phase of Covid-19 and Its Implemented Treatment Strategies
Sadhukhan, P., Sutnga, I., Bingari, B., & Choudhury, A. (2021) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v11i3-s.4868 · Cited by 1
Status of Humoral and Cellular Immune Responses within 12 Months Following CoronaVac Vaccination Against COVID-19Preprint
Zhao, W., Chen, W., Li, J., Cheng, M., Li, Q., Lv, M., Zhou, S., Bai, S., Wang, Y., Zhang, L., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3945456
At a glance on Coronavirus Disease (COVID-19): Pathogenesis, Innate and acquired mechanisms, Host-virus genomes interactions, Therapeutic options and prevention (Preprint)Preprint
Singh, D. D. (2020) · doi:10.2196/preprints.20602
Intracavitary Bacillus Calmette-Guérin Treatment for Bladder Cancer: Is it Protective Against COVID-19?
Keskin, M. Z., Özbilen, M. H., & Teker, K. (2022) · The Anatolian Journal of General Medical Research · doi:10.4274/terh.galenos.2022.61214
SARS-CoV-2: Recent Past and Present: An Unusual Review
Mulengi, J. K. (2022) · African Journal of Pharmaceutical Sciences · doi:10.51483/afjps.2.2.2022.1-33
Relevance for mRNA Vaccine Safety
Mueller, S. (2022) · Springer eBooks · doi:10.1007/978-3-031-18903-6_3
Vaccine Compliance Versus Trust in a Pandemic
Stone, J. (2023) · Integrated science · doi:10.1007/978-3-031-17778-1_24
Comparison of T cell maturation profiles in the 1st and 5th wave of COVID-19 in the Polish population
Rutkowska, E., Kwiecień, I., Raniszewska, A., Kłos, K., Melnicka, I., Rzepecki, P., & Chciałowski, A. (2024) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/186813
Characterization of the immune response with viral attack
Pattanayak, S. P., Ranjan, G., Dasgupta, S., & Sunita, P. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-19170-1.00023-1
Risk factors for Mortality in Patients with COVID-19 in Cuernavaca-Morelos
Rodríguez, J. M., Albavera-Hernández, C., Hidalgo-Troya, A., Piñeros-Garzón, F. S., & Rojas, S. R. (2025) · Current Respiratory Medicine Reviews · doi:10.2174/011573398x336783250117111654
What needs to go right to get a coronavirus vaccine in 12-18 months
García‐Ojeda, M. E. (2020) · doi:10.64628/aai.wg9rwxucv
Additional file 6 of Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workers
Jackson-Thompson, B. M., Goguet, E., Laing, E. D., Olsen, C. H., Pollett, S., Hollis-Perry, K. M., Maiolatesi, S. E., Illinik, L., Ramsey, K. F., Reyes, A. E., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14759630
Additional file 5 of An integrative bioinformatics analysis for identifying hub genes associated with infection of lung samples in patients infected with SARS-CoV-2
Xie, T., He, Z.-J., Liang, C., Dong, H.-N., Zhou, J., Fan, S.-J., & Guo, X.-G. (2021) · Figshare · doi:10.6084/m9.figshare.17273301
Additional file 2 of Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workers
Jackson-Thompson, B. M., Goguet, E., Laing, E. D., Olsen, C. H., Pollett, S., Hollis-Perry, K. M., Maiolatesi, S. E., Illinik, L., Ramsey, K. F., Reyes, A. E., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14759618
Additional file 1 of Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workers
Jackson-Thompson, B. M., Goguet, E., Laing, E. D., Olsen, C. H., Pollett, S., Hollis-Perry, K. M., Maiolatesi, S. E., Illinik, L., Ramsey, K. F., Reyes, A. E., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14759615
Additional file 4 of An integrative bioinformatics analysis for identifying hub genes associated with infection of lung samples in patients infected with SARS-CoV-2
Xie, T., He, Z.-J., Liang, C., Dong, H.-N., Zhou, J., Fan, S.-J., & Guo, X.-G. (2021) · Figshare · doi:10.6084/m9.figshare.17273298
Additional file 2 of An integrative bioinformatics analysis for identifying hub genes associated with infection of lung samples in patients infected with SARS-CoV-2
Xie, T., He, Z.-J., Liang, C., Dong, H.-N., Zhou, J., Fan, S.-J., & Guo, X.-G. (2021) · Figshare · doi:10.6084/m9.figshare.17273292
Additional file 5 of Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workers
Jackson-Thompson, B. M., Goguet, E., Laing, E. D., Olsen, C. H., Pollett, S., Hollis-Perry, K. M., Maiolatesi, S. E., Illinik, L., Ramsey, K. F., Reyes, A. E., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14759627
Additional file 3 of Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workers
Jackson-Thompson, B. M., Goguet, E., Laing, E. D., Olsen, C. H., Pollett, S., Hollis-Perry, K. M., Maiolatesi, S. E., Illinik, L., Ramsey, K. F., Reyes, A. E., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14759621
Additional file 7 of Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workers
Jackson-Thompson, B. M., Goguet, E., Laing, E. D., Olsen, C. H., Pollett, S., Hollis-Perry, K. M., Maiolatesi, S. E., Illinik, L., Ramsey, K. F., Reyes, A. E., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14759633
Additional file 3 of An integrative bioinformatics analysis for identifying hub genes associated with infection of lung samples in patients infected with SARS-CoV-2
Xie, T., He, Z.-J., Liang, C., Dong, H.-N., Zhou, J., Fan, S.-J., & Guo, X.-G. (2021) · Figshare · doi:10.6084/m9.figshare.17273295
Additional file 8 of Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workers
Jackson-Thompson, B. M., Goguet, E., Laing, E. D., Olsen, C. H., Pollett, S., Hollis-Perry, K. M., Maiolatesi, S. E., Illinik, L., Ramsey, K. F., Reyes, A. E., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14759636
Additional file 1 of An integrative bioinformatics analysis for identifying hub genes associated with infection of lung samples in patients infected with SARS-CoV-2
Xie, T., He, Z.-J., Liang, C., Dong, H.-N., Zhou, J., Fan, S.-J., & Guo, X.-G. (2021) · Figshare · doi:10.6084/m9.figshare.17273289
Additional file 9 of Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workers
Jackson-Thompson, B. M., Goguet, E., Laing, E. D., Olsen, C. H., Pollett, S., Hollis-Perry, K. M., Maiolatesi, S. E., Illinik, L., Ramsey, K. F., Reyes, A. E., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14759639
Additional file 4 of Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workers
Jackson-Thompson, B. M., Goguet, E., Laing, E. D., Olsen, C. H., Pollett, S., Hollis-Perry, K. M., Maiolatesi, S. E., Illinik, L., Ramsey, K. F., Reyes, A. E., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14759624
T immune responses to SARS-CoV-2 : identification of the immunogenic region associated with protection against infection
Fahrner, J. (2021) · theses.fr (ABES) · doi:10.70675/6b8b8b92zda75z46a0z98e6zc9f888cb9715
Modéliser la propagation et le contrôle du SARS-CoV-2 en France
Kiem, C. T. (2022) · theses.fr (ABES) · doi:10.70675/ee2d278bz060dz47c1za2c7zde12caebb50b
Clinical symptoms associated with RT-PCR positivity among hospitalized suspected COVID-19 patients: a descriptive-analytical study in Abarkuh, Iran
Askari, M., Dadbinpour, A., Azimi, S. M., Asgarnehad, A. A., & Basiri, A. (2026) · Journal of Health Research and Development · doi:10.66224/jhrd.4.1.34
T and B cell responses to SARS-CoV-2 coronavirus
Sette, A. (2020) · ImmPort · doi:10.21430/m3czdhcxkv

Authors: Peeples, L.
Corresponding author: Peeples, Lynne
Venue: Proceedings of the National Academy of Sciences
Publisher: National Academy of Sciences
Published: 2020-03-30
Volume: 117
Issue: 15
Pages: 8218-8221
ISSN: 0027-8424 (ISSN-L)
1091-6490
DOI: 10.1073/pnas.2005456117
PMC: PMC7165470
OpenAlex: W3013160031
Cited by: 152
References: 8
Citations by year: 2026: 1 · 2025: 3 · 2024: 2 · 2023: 8 · 2022: 16 · 2021: 56 · 2020: 66
FWCI: 4.82
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.pnas.org/site/aboutpnas/licenses.xhtml (vor, 184 d)
Locations: Proceedings of the National Academy of Sciences (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Keywords: COVID-19 vaccines, immune enhancement, vaccine safety, SARS-CoV-2, vaccine candidate, immune response
MeSH terms: Betacoronavirus, COVID-19, SARS-CoV-2, COVID-19 Vaccines, Animals, Antigens, Viral, Clinical Trials as Topic, Humans, Inflammation, Pneumonia, Viral, T-Lymphocytes, Viral Vaccines, Coronavirus Infections, Antibody-Dependent Enhancement, Severe Acute Respiratory Syndrome, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Avoiding pitfalls in the pursuit of a COVID-19 vaccine

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks